Purdue Pharma creditors’ committee urges one mass settlement for all opioid lawsuits

Associated Press
Purdue Pharma creditors’ committee urges one mass settlement for all opioid lawsuits

A committee guiding OxyContin maker Purdue Pharma’s bankruptcy has suggested other drugmakers, distributors and pharmacy chains use Purdue’s bankruptcy proceedings to settle more than 2,000 lawsuits seeking to hold the drug industry accountable for the national opioid crisis.